Teva, Allergan settle Rhode Island opioid suit for $107M: 3 notes

Allergan and Teva Pharmaceuticals have settled allegations that they helped fuel Rhode Island’s opioid epidemic, state Attorney General Peter Neronha said March 21.

Advertisement

Three notes:

1. As part of the settlement, the drugmakers will pay the state a combined $28.5 million in cash over the next 13 years.

2. They’ll also give Rhode Island 1 million doses of naloxone, which can be used to reverse the effects of an opioid overdose, and 67,000 30-pill bottles of Suboxone, a medication used to treat opioid use disorder, in various doses for free over the next 10 years.

3. The deal results in a combined settlement value of $107 million. 

Advertisement

Next Up in Legal & Regulatory Issues

  • CMS established a new physician nutrition specialist specialty code, effective beginning Oct. 1. The code helps physician nutrition specialists —…

  • Two Minnesota health systems announced plans to combine into a 22-hospital system, and UPMC finalized a deal that moves it…

  • York (Maine) Hospital officially joined Portland-based MaineHealth Oct. 1, according to a post on the hospital’s Facebook page.  The hospital…

Advertisement

Comments are closed.